C-Rad AB (LTS:0R44) Short Interest


LTS:0R44 C-Rad AB LTS:0R44
83 GF Score
Price kr35.90
GF Value kr33.44
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is C-Rad AB Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0R44 vs ABT, SYK, MDT: Short Interest Comparison

For the Medical Devices subindustry, C-Rad AB's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

C-Rad AB Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, C-Rad AB's Short Interest distribution charts can be found below:

* The bar in red indicates where C-Rad AB's Short Interest falls into.


LTS:0R44
83GF Score
C-Rad AB LTS:0R44
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is C-Rad AB (LTS:0R44) Overvalued in 2026?

Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued. The current stock price of kr35.90 is trading 7.4% above its estimated GF Value™ of kr33.44. GuruFocus considers C-Rad AB to be Fairly Valued.

Key valuation signals for LTS:0R44:

  • Short Interest:
  • GF Value™: kr33.44 vs. price of kr35.90 (7.4% above fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the LTS:0R44 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-Rad AB Business Description

Other Exchanges CRAD B:Sweden24C:Germany
Address Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
83GF Score

Get the complete analysis for LTS:0R44

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr35.90
Price
kr33.44
GF Value